CMRX $2.10 in cash and no debt / enough to sustain through 2026 smart investors / Insiders are buying as well / year end tax loss harvesting is almost done and I believe biotechs will run fast in jan / feb
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.840 EUR
−74.38 M EUR
293.55 K EUR
80.14 M
About Chimerix, Inc.
Sector
CEO
Michael T. Andriole
Headquarters
Durham
Website
Founded
2000
FIGI
BBG004FSD6S5
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
CMRX waiting for news Now we just need some news to get dropped. Some positive ones, and we are ready to do.
target 2.90 ( 1 to 5 months )Good Technical ( Nice Breakout ) and Good Fundamental ( Good Result ) , So Target 2.90 , Duration 1 to 5 months.
Chimerix Awarded BARDA Contract for TEMBEXACMRX: Chimerix, Inc.
2022-08-29 10:45:00 Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
Chimerix Announces Positive Topline Results for ONC201 in RecurrCMRX: Chimerix, Inc.
2021-11-04 07:00:00
Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma
CMRX 2/7/2020Analysis-
Daily chart- After long downtrend, price has been in sideways market between 1.24-3.38 for 638 days. After making a move to resistance on July2020, price fell and found support from 200 MA then working itself back to resistance and finally breaking out. After breakout of 40%, price pulled
CMRX descending wedge formedsimple wedge formed in order to add onto my long term hold once we hopefully bounce off of the 3.26 fib level
CMRX daily 160% gains setup(STOCKS)before we kick start the update. your upvotes/subs are appreciated.
Why get subbed to to me on Tradingview?
-15+ years real live trading experience
-TOP Author on TradingView
-professional chart break downs
-key levels
-no junk on my charts
-frequent updates
-covering FX/crypto/US stocks
-24/7
$CMRX Chimerix Inc Moving big pore market - Covid-19DURHAM, N.C., April 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the Company’s initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19 patie
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHIMERIX INC. DL -,001 stocks are traded under the ticker CXF.
We've gathered analysts' opinions on CHIMERIX INC. DL -,001 future price: according to them, CXF price has a max estimate of 10.42 EUR and a min estimate of 5.69 EUR. Watch CXF chart and read a more detailed CHIMERIX INC. DL -,001 stock forecast: see what analysts think of CHIMERIX INC. DL -,001 and suggest that you do with its stocks.
Yes, you can track CHIMERIX INC. DL -,001 financials in yearly and quarterly reports right on TradingView.
CHIMERIX INC. DL -,001 is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
CXF earnings for the last quarter are −0.23 EUR per share, whereas the estimation was −0.21 EUR resulting in a −10.17% surprise. The estimated earnings for the next quarter are −0.25 EUR per share. See more details about CHIMERIX INC. DL -,001 earnings.
CHIMERIX INC. DL -,001 revenue for the last quarter amounts to 23.35 K EUR, despite the estimated figure of 280.22 K EUR. In the next quarter, revenue is expected to reach 290.37 K EUR.
CXF net income for the last quarter is −20.55 M EUR, while the quarter before that showed −19.31 M EUR of net income which accounts for −6.41% change. Track more CHIMERIX INC. DL -,001 financial stats to get the full picture.
No, CXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 9, 2025, the company has 72.00 employees. See our rating of the largest employees — is CHIMERIX INC. DL -,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHIMERIX INC. DL -,001 EBITDA is −83.39 M EUR, and current EBITDA margin is −28.72 K%. See more stats in CHIMERIX INC. DL -,001 financial statements.
Like other stocks, CXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHIMERIX INC. DL -,001 stock right from TradingView charts — choose your broker and connect to your account.